New research reveals the egg chooses the sperm

New research reveals the egg chooses the sperm

Studies that have recently come out of Sweden have revealed that a woman’s eggs may play a crucial role in selecting sperm.

Researchers from Stockholm University analysed samples of sperm and follicular fluid and found that some of the samples of follicular fluid attracted more sperm than others.

Eggs release chemicals called chemoattractants, which are small soluble proteins that create an attraction between the egg and the sperm. The eggs will use these chemical signals to help guide the sperm which will increase the likelihood of fertilisation. The signal produced by the egg will encourage the selected sperm to swim faster and straighter to help them reach the correct place whereas it will also signal for the undesirable sperm to “slow down”.

This study has revealed that it is possible that eggs could be attracted more to sperm that are genetically compatible, which will increase the likelihood of fertilisation. This also shows that in couples who are having trouble conceiving naturally with no clear cause, it is possible that the chemical signalling between the egg and the sperm be the reason.

Although there is a need for future research in this area, this has given us some incredible insight into how the egg will potentially “choose” sperm and more importantly, this information could help advance fertility treatments worldwide, especially in cases where with many frustrated couples, their inability to conceive is simply “unexplained”.

Share

Fertility Testing News & Information

FAQ

How does Fertility First keep fertility treatment and IVF costs down?

As a Doctor-owned Medical Practice, our fertility and IVF treatment costs do not need to cover overheads and/or shareholder dividends, all of which have to come out of the income derived from patients’ treatment cycle fees at other fertility clinics in Sydney.

What is the NSW fertility treatment rebates?

From the 1st October 2022, the NSW Government announced a rebate of $2,000 in OOP expenses for all eligible patients. Fertility First is pleased to support the NSW Government’s fertility rebate at our Sydney fertility clinic.

What makes Fertility First different to other Sydney fertility clinics?

Fertility First is privately owned, which means we can place more focus on our patients. We offer a holistic approach to fertility and believe that it’s important to minimise the invasiveness of the fertility testing process and only carry out the necessary investigations, maximising your chance of a successful outcome. We offer extensive preliminary fertility testing, including Halosperm Assay.

We were one of the first Sydney fertility clinics to offer a donor sperm and donor egg program, thanks to our partnership with Central IVF.

How do I choose the best fertilty clinic for me?

Choosing the right fertility clinic in Sydney is a very important decision. You should consider factors like success rates, clinic location and appointment times, fertility treatment costs, repor with the Fertility Specialist and what treatment options are available.

Does Fertility First offer preliminary fertility testing?

Yes. We offer a range of fertility testing for both males and females. We aim to have fertility test results back within 2 to 3 weeks, which means, unless any assessment of the fallopian tubes is required, fertility treatment options can then be considered.

Does Fertility First offer treatment for same sex couples and singles?

Yes. Fertility First offers a range of fertility treatments that are suitable for same sex couples and singles, including our donor sperm program. See our fertility treatment page for a full guide.

Does Fertility First offer Medicare rebates?

Yes. In order to assist you with a Medicare rebate for your fertility treatment, you will need a current referral to Fertility First.

Note: GP referrals are valid for 12 months, and specialist referrals are valid for 3 months.

Does Fertility First offer IVF treatment?

Yes. IVF treatment is offered to suitable patients after preliminary testing.